ОбзорГрафикНовостиTraderScreen

Citi Knock-Out LLY/  DE000KJ036Y2  /

Frankfurt Zert./CITI
27.09.2024  19:37:33 Изменение-2.230 Бид21:59:28 Предложение- Базовый актив Цена исполнения Дата истечения Тип опциона
25.610EUR -8.01% -
Величина цены спроса: -		 -
Величина цены предложения: -		 ELI LILLY 600.389 - 31.12.2078 Call
TeleTrader 11:34 Yellen to say Trump's tariffs would boost prices
TeleTrader 11:01 Eurozone's trade surplus at €4.6B in August
TeleTrader 11:00 Eurozone inflation down from 2.2% to 1.7% in September
TeleTrader 10:50 China says it invited EU team to discuss EV tariffs
TeleTrader 10:45 Hezbollah commander killed as IDF targets 150 sites
TeleTrader 10:40 EU's Borrell: US pressure on Israel insufficient
TeleTrader 10:17 US mostly up premarket ahead of data, Netflix earnings
TeleTrader 9:48 Israeli army orders evacuation of Lebanon's Beqaa Valley
TeleTrader 9:31 UK top diplomat Lammy to visit China this week
TeleTrader 9:21 IRGC's chief warns Israel of 'painful' response if attacks happen
TeleTrader 9:00 Europe opens mostly higher with ECB, data in focus
TeleTrader 8:32 S. Korea, US to prepare for N. Korea's possible actions
TeleTrader 8:30 Tayr Debba in southern Lebanon hit by Israeli strike, 3 killed
TeleTrader 8:02 Swiss trade surplus at 11.3B francs in Q3
TeleTrader 8:00 Europe premarket lower to flat with eyes on ECB's rate decision
TeleTrader 7:36 TSMC's Q3 net sales up by 39% to $23.5 billion
TeleTrader 7:33 Asia-Pacific mostly higher amid data, earnings
TeleTrader 7:05 Nestle sales down 2.4% to 67.1B Swiss francs in 9M
TeleTrader 6:54 China to boost funds for housing projects to $562B
TeleTrader 6:39 Official claims West allowed Ukraine's strikes deep into Russia
TeleTrader 6:14 N. Korea's changed constitution designates South 'hostile state'
TeleTrader 6:01 PREVIEW: Will the ECB deliver another rate cut?
TeleTrader 5:29 US strikes Houthi weapons storage sites with B-2 bombers
TeleTrader 5:05 Official: GM, Foxconn to swap imports to Mexico for local production
TeleTrader 4:25 Moderna sued for patent infringement over COVID-19 vaccines